Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Naofumi Hashimoto"'
Autor:
Kayo Yuminoki, Fuko Seko, Shota Horii, Haruka Takeuchi, Katsuya Teramoto, Yuichiro Nakada, Naofumi Hashimoto
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 11, Iss 1, Pp 48-49 (2016)
Externí odkaz:
https://doaj.org/article/532e854552f448d6a46b57fd70e87413
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 11, Iss 1, Pp 122-123 (2016)
Externí odkaz:
https://doaj.org/article/84f0e518aaae48ca8de9a252ea173f36
Autor:
Ryoka Goto, Misa Minami, Itsuki Uno, Mizuki Yamaguchi, Kazunori Inaba, Kousuke Takemoto, Motoki Nakao, Naofumi Hashimoto, Noriaki Nagai
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:225-233
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a6b2147e682e75efa6b5efe48716c31
https://doi.org/10.5649/jjphcs.47.225
https://doi.org/10.5649/jjphcs.47.225
Autor:
Yusuke Hattori, Yuka Hoshi, Naofumi Hashimoto, Yasunori Ichimura, Yasuo Sugiura, Makoto Otsuka
Publikováno v:
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. 38(10)
In this work, we optimized classification algorithms and the hyperparameters for screening falsified and substandard amoxicillin capsules. The distribution of low-quality medical products is a serious problem, especially in low- and middle-income cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a18d65bc74bffea71fc52e1e8d4bdf80
https://pubmed.ncbi.nlm.nih.gov/35939234
https://pubmed.ncbi.nlm.nih.gov/35939234
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb900de8f92488692d322c0929ec69f
https://doi.org/10.2139/ssrn.4179098
https://doi.org/10.2139/ssrn.4179098
Publikováno v:
Journal of Drug Delivery Science and Technology. 79:104013
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8399c08dc73b2ce4b832a7321b2d277
https://doi.org/10.1016/j.jddst.2022.104013
https://doi.org/10.1016/j.jddst.2022.104013
Autor:
Satomi Onoue, Kayo Yuminoki, Yoshiki Kojo, Hiroki Suzuki, Hideyuki Sato, Yoshiki Seto, Naofumi Hashimoto, Yuuki Kaneko, Kouki Kato
Publikováno v:
International Journal of Pharmaceutics. 545:19-26
The present study aimed to clarify the applicability of a self-micellizing solid dispersion of tranilast (SMSD/TL) to the treatment of inflammatory bowel diseases (IBD) using an experimental colitis model. SMSD/TL with several loading amounts ranging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e23a235ee4aceb64d3a3955063129646
https://doi.org/10.1016/j.ijpharm.2018.04.053
https://doi.org/10.1016/j.ijpharm.2018.04.053
Autor:
Atsushi Kanda, Naofumi Hashimoto, Keisuke Kimura, Takaki Kawachi, Akitoshi Matsuda, Kayo Yuminoki, Masanori Ochi
Publikováno v:
AAPS PharmSciTech. 17:932-939
The aim of the present study was to develop amorphous solid dispersion (ASD) of meloxicam (MEL) for providing rapid onset of action. ASDs of MEL with polyvinylpyrrolidone (PVP) K-30 (MEL/PVP), HPC-SSL (MEL/HPC), and Eudragit EPO (MEL/EPO) were prepar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a41c748203ac20e6b5a6b7d9925023
https://doi.org/10.1208/s12249-015-0422-x
https://doi.org/10.1208/s12249-015-0422-x
Autor:
Hideyuki Sato, Satomi Onoue, Hiroki Suzuki, Yoshiki Kojo, Kayo Yuminoki, Shizuo Yamada, Saori Matsunaga, Takahiro Mizumoto, Naofumi Hashimoto
Publikováno v:
European Journal of Pharmaceutical Sciences. 62:16-22
The present study aimed to develop a self-micellizing solid dispersion (SMSD) of cyclosporine A (CsA) using an amphiphilic block copolymer, poly[MPC-co-BMA], to improve the biopharmaceutical properties of CsA. The cytotoxicity of poly[MPC-co-BMA] was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508ad8ad2fa07125ed46ccff3c067e32
https://doi.org/10.1016/j.ejps.2014.05.006
https://doi.org/10.1016/j.ejps.2014.05.006
Autor:
Satomi Onoue, Issei Hashimoto, Naofumi Hashimoto, Kayo Yuminoki, Takaki Kawachi, Eri Toita, Masanori Ochi
Publikováno v:
International Journal of Pharmaceutics. 474:151-156
The present study aimed to develop nanocrystal formulations of meloxicam (MEL) in order to enhance its biopharmaceutical properties and provide a rapid onset of action. Nanocrystal formulations were prepared by wet-milling and lyophilization with hyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba06be5a7b5cd40f6d291dca14245b56
https://doi.org/10.1016/j.ijpharm.2014.08.022
https://doi.org/10.1016/j.ijpharm.2014.08.022